S&P Futures

7,412.50

+10.50

+0.14%

Dow Futures

51,616.00

+231.00

+0.45%

Nasdaq Futures

26,992.25

-93.00

-0.34%

Russell 2000 Futures

2,777.40

+16.90

+0.61%

10-Yr Bond

4.8590

+0.0220

+0.45%

VIX

25.64

-2.54

-9.01%

Gold

4,110.60

+35.70

+0.88%

Bitcoin USD

73,838.96

-2,017.00

-2.66%

Crude Oil Dec 26

90.19

-0.64

-0.70%

US Private Equity

10,772.76

+11.83

+0.11%

NSE - Free Realtime Quote INR

Wockhardt Limited (WOCKPHARMA.NS)

2,044.00 +37.70 (+1.88%)

As of 12:57:08 PM GMT+5:30. Market Open.

Loading Chart for WOCKPHARMA.NS

Chart Range Bar

Interval:

In partnership with ChartIQ

Complicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics’ UTEBZI and Wockhardt’s ZAYNICH and Emerging Therapies | DelveInsight

Piyush Goyal and UK-India FTA Negotiation Teams Honoured at 10th Anniversary of IGF UK-India Awards

Mobilize your Website

View Site in Mobile | Classic

Share by:

U.S. markets open in 7h 4m

Wockhardt Limited (WOCKPHARMA.NS)

Recent News

Complicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics’ UTEBZI and Wockhardt’s ZAYNICH and Emerging Therapies | DelveInsight

Piyush Goyal and UK-India FTA Negotiation Teams Honoured at 10th Anniversary of IGF UK-India Awards

Related Tickers